Evaluate the safety and efficacy of oral Tramadol in patients undergoing colonoscopy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015010820610N1

Enrollment

Registered

2015-02-22

Start date

2014-09-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases of the digestive system. Other diseases of the digestive system

Interventions

Intervention 1: Intervention: oral Tramadol One pill of oral Tramadol , 4 hours before colonoscopy. Intervention 2: Control group: Multivitamin One pill of oral Multivitamin , 4 hours before colo

Treatment - Drugs

Intervention: oral Tramadol One pill of oral Tramadol , 4 hours before colonoscopy

Control group: Multivitamin One pill of oral Multivitamin , 4 hours before colonoscopy

Eligibility

Sex/Gender

All

Age

20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age between 20 to 65 years, for whatever reason are candidates for colonoscopy. Exclusion criteria: People who have a history of drug abuse,People who have drug allergies, Heart disease, Or chronic systemic diseases.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain density. Timepoint: During colonoscopy. Method of measurement: Visual Analogue Scale for pain.	—

Secondary

Measure	Time frame
Safety and efficacy of oral tramadol on pain. Timepoint: During colonoscopy. Method of measurement: Visual Analogue Scale for pain.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTeymor kamari

Kermanshah University of Medical Sciences

t.kamari@kums.ac.ir+98 83 3427 6309

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 15, 2026